Doximity, Inc. DOCS
6 trading plans running, 22 Form 144 notices for $3.7M
10-Q, 10-K and Form 144What DOCS's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Nov 12, 2024 to May 26, 2028. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| Matthew Sonefeldt Chief Financial Officer |
Adopted 10b5-1 plan | Aug 31, 2026 | 10-Q Nov 5, 2026 | ||
What the company wroteOn August 31, 2026, Mr. Matthew Sonefeldt, Chief Financial Officer of the Company, adopted a Rule 10b5-1 trading plan with a term expiring on August 31, 2027, providing for the sale of up to 17,644 shares of the Company’s Class A common stock and other net vested shares of Class A common stock pursuant to a series of market orders. | |||||
| John Vaughan General Counsel of the Company |
Adopted 10b5-1 plan | Aug 11, 2026 | 10-Q Nov 5, 2026 | ||
What the company wroteOn August 11, 2026, Mr. John Vaughan, General Counsel of the Company, adopted a Rule 10b5-1 trading plan with a term expiring on June 1, 2027, providing for the sale of a portion of the shares of the Company’s Class A common stock acquired through the Company’s employee stock purchase plan. | |||||
| Kira Wampler director of the Company |
Adopted 10b5-1 plan | May 26, 2026 | 10-Q Aug 6, 2026 | ||
What the company wroteOn May 26, 2026, Ms. Kira Wampler, a director of the Company, adopted a Rule 10b5-1 trading plan with a term expiring on May 26, 2028, providing for the sale of up to 54,000 shares of stock issuable upon the exercise of vested stock options. | |||||
| Phoebe Yang director of the Company |
Adopted 10b5-1 plan | May 22, 2026 | 10-Q Aug 6, 2026 | ||
What the company wroteOn May 22, 2026, Ms. Phoebe Yang, a director of the Company, adopted a Rule 10b5-1 trading plan with a term expiring on October 14, 2026, providing for the sale of up to 1,290 shares of common stock. | |||||
| Anna Bryson Chief Financial Officer |
Ended 10b5-1 plan | Apr 27, 2026 | 10-Q Aug 6, 2026 | ||
What the company wroteOn April 27, 2026, Ms. Anna Bryson, former Chief Financial Officer of the Company, terminated a Rule 10b5-1 trading plan that she had previously entered into on May 27, 2025. The plan, which was scheduled to expire pursuant to its terms on May 27, 2026, provided for the sale of up to 160,000 shares of the Company’s Class A common stock issuable upon the exercise of vested stock options. A total of 40,000 shares were sold under the plan prior to its termination. | |||||
| Siddharth Sitaram Chief Accounting Officer |
Adopted 10b5-1 plan | Feb 27, 2026 | 10-K May 19, 2026 | ||
What the company wroteOn February 27, 2026, Mr. Siddharth Sitaram, Chief Accounting Officer, adopted a Rule 10b5-1 Trading Plan that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Mr. Sitaram’s Rule 10b5-1 Trading Plan, which has a term from February 27, 2026 to December 31, 2026, provides for the potential exercise of 38,800 vested stock options and the associated sale of sufficient shares of the Company’s Class A common stock to cover exercise costs and estimated tax withholding amounts plus customary brokerage fess pursuant to a series of market orders. | |||||
| Tim Cabral director of the Company |
Adopted 10b5-1 plan | Feb 19, 2026 | 10-K May 19, 2026 | ||
What the company wroteOn February 19, 2026, Mr. Tim Cabral, a director of the Company, adopted a Rule 10b5-1 Trading Plan that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Mr. Cabral’s Rule 10b5-1 Trading Plan, which has a term from February 19, 2026 to May 21, 2027, provides for the potential exercise of vested stock options and the associated sale of up to 60,000 shares of the Company’s Class A common stock in the aggregate and other net vested shares of Class A common stock pursuant to a series of market orders. On the date of the execution of Mr. Cabral’s Rule 10b5-1 Trading Plan, he held no net vested shares. Mr. Cabral’s net vested share amount will change as additional equity awards vest or shares are subsequently purchased or sold during the term of his Rule 10b5-1 Trading Plan. | |||||
| Ms. Phoebe Yang director |
Adopted 10b5-1 plan | Nov 26, 2025 | 10-Q Feb 5, 2026 | ||
What the company wroteOn November 26, 2025, Ms. Phoebe Yang, a director of the Company, adopted a Rule 10b5-1 Trading Plan that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Ms. Yang’s Rule 10b5-1 Trading Plan, which has a term from November 26, 2025 to November 26, 2027, provides for the sale of 3,000 shares of common stock pursuant to a series of market orders. On the date of the execution of Ms. Yang’s Rule 10b5-1 Trading Plan, Ms. Yang held 14,729 shares of common stock. Ms. Yang’s net vested share amount will change as additional equity awards vest or shares are subsequently purchased or sold during the term of Ms. Yang’s Rule 10b5-1 Trading Plan. | |||||
| Anna Bryson Chief Financial Officer |
Ended 10b5-1 plan | May 22, 2025 | 10-Q Aug 7, 2025 | ||
What the company wroteOn May 27, 2025, Ms. Bryson, adopted a new Rule 10b5-1 Trading Plan that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Ms. Bryson’s new Rule 10b5-1 Trading Plan, which has a term from May 27, 2025 to May 27, 2026, provides for the exercise and sale of 160,000 shares of common stock pursuant to a series of market orders. | |||||
| Regina Benjamin director |
Adopted 10b5-1 plan | Feb 26, 2025 | 10-K May 20, 2025 | ||
What the company wroteOn February 26, 2025, Dr. Regina Benjamin, a director of the Company, adopted a Rule 10b5-1 trading arrangement for the sale of the Company’s Class A common stock (a “Rule 10b5-1 Trading Plan”) that is intended to satisfy the affirmative defense conditions of Exchange Act Rule 10b5-1(c). Dr. Benjamin’s Rule 10b5-1 Trading Plan, which has a term from February 26, 2025 to May 28, 2026, provides for the potential exercise of vested stock options and the associated sale of up to 65,000 shares of the Company’s Class A common stock in the aggregate pursuant to a series of market orders. | |||||
| Tim Cabral director |
Adopted 10b5-1 plan | Feb 13, 2025 | 10-K May 20, 2025 | ||
What the company wroteOn February 13, 2025, Mr. Tim Cabral, a director of the Company, adopted a Rule 10b5-1 Trading Plan that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Mr. Cabral’s Rule 10b5-1 Trading Plan, which has a term from February 13, 2025 to May 15, 2026, provides for the potential exercise of vested stock options and the associated sale of up to 120,000 shares of the Company’s Class A common stock in the aggregate and other net vested shares of Class A common stock pursuant to a series of market orders. On the date of the execution of Mr. Cabral’s Rule 10b5-1 Trading Plan, he held no net vested shares. Mr. Cabral’s net vested share amount will change as additional equity awards vest or shares are subsequently purchased or sold during the term of his Rule 10b5-1 Trading Plan. | |||||
| Phoebe Yang director |
Ended 10b5-1 plan | Feb 12, 2025 | 10-K May 20, 2025 | ||
What the company wroteOn February 12, 2025, Ms. Phoebe Yang, a director of the Company, terminated a Rule 10b5-1 Trading Plan that she had previously entered into on November 12, 2024. Ms. Yang’s Rule 10b5-1 Trading Plan, which was scheduled to expire pursuant to its terms on September 19, 2025, provided for the sale of 33.33% of net vested shares of Class A common stock pursuant to a series of market orders. | |||||
| Anna Bryson Chief Financial Officer |
Adopted 10b5-1 plan | Nov 12, 2024 | 10-Q Feb 6, 2025 | ||
What the company wroteOn November 12, 2024, Ms. Anna Bryson, the Chief Financial Officer of the Company, adopted a Rule 10b5-1 Trading Plan that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Ms. Bryson’s Rule 10b5-1 Trading Plan, which has a term from November 12, 2024 to May 29, 2026, provides for the exercise and sale of 375,000 shares of common stock pursuant to a series of market orders. | |||||
| Kira Wampler director |
Adopted 10b5-1 plan | Nov 12, 2024 | 10-Q Feb 6, 2025 | ||
What the company wroteOn November 12, 2024, Ms. Kira Wampler, a director of the Company, adopted a Rule 10b5-1 trading arrangement for the sale of securities of the Company’s common stock (a “Rule 10b5-1 Trading Plan”) that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Ms. Wampler’s Rule 10b5-1 Trading Plan, which has a term from November 12, 2024 to November 12, 2026 , provides for the exercise and sale of 54,000 shares of common stock pursuant to a series of market orders. | |||||
| Phoebe Yang director |
Adopted 10b5-1 plan | Nov 12, 2024 | 10-Q Feb 6, 2025 | ||
What the company wroteOn November 12, 2024, Ms. Phoebe Yang, a director of the Company, adopted a Rule 10b5-1 Trading Plan that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Ms. Yang’s Rule 10b5-1 Trading Plan, which has a term from November 12, 2024 to September 19, 2025, provides for the sale of 33.33% of net vested shares of common stock pursuant to a series of market orders. On the date of the execution of Ms. Yang’s Rule 10b5-1 Trading Plan, Ms. Yang held 8,370 net vested shares. Ms. Yang’s net vested share amount will change as additional equity awards vest or shares are subsequently purchased or sold during the term of Ms. Yang’s Rule 10b5-1 Trading Plan. | |||||
| Tim Cabral director |
Adopted 10b5-1 plan | Feb 15, 2024 | 10-K May 23, 2024 | ||
What the company wroteOn February 15, 2024, Mr. Tim Cabral, a director of the Company, adopted a Rule 10b5-1 Trading Plan that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Mr. Cabral’s Rule 10b5-1 Trading Plan, which has a term from February 15, 2024 to February 28, 2025, provides for the exercise and sale of 80,000 shares of common stock pursuant to a series of market orders. The plan also provides for the sale of an indeterminate number of net vested shares of common stock pursuant to a market order. On the date of the execution of Mr. Cabral’s Rule 10b5-1 Trading Plan, Mr. Cabral did not hold any net vested shares. Mr. Cabral’s net vested share amount is currently indeterminable because it will change as additional equity awards vest or shares are subsequently purchased or sold. | |||||
| Ms. Anna Bryson Chief Financial Officer |
Adopted 10b5-1 plan | Nov 30, 2023 | 10-Q Feb 8, 2024 | ||
What the company wroteOn November 30, 2023, Ms. Anna Bryson, the Chief Financial Officer of the Company, adopted a Rule 10b5-1 trading arrangement for the sale of securities of the Company’s common stock (a “Rule 10b5-1 Trading Plan”) that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Ms. Bryson’s Rule 10b5-1 Trading Plan, which has a term from November 30, 2023 to November 29, 2024, provides for the exercise and sale of 120,000 shares of common stock pursuant to a series of market orders. | |||||
| Ms. Phoebe Yang director of the Company |
Adopted 10b5-1 plan | Aug 30, 2023 | 10-Q Nov 9, 2023 | ||
What the company wroteOn August 30, 2023, Ms. Phoebe Yang, a director of the Company, adopted a Rule 10b5-1 Trading Plan that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Ms. Yang’s Rule 10b5-1 Trading Plan, which has a term from August 30, 2023 to August 14, 2024, provides for the sale of 35% of net vested shares of common stock pursuant to a series of market orders. On the date of the execution of Ms. Yang’s Rule 10b5-1 Trading Plan, Ms. Yang held 2,889 net vested shares. Ms. Yang’s net vested share amount will change as additional equity awards vest or shares are subsequently purchased or sold. | |||||
| Ms. Kira Wampler director of the Company |
Adopted 10b5-1 plan | Aug 24, 2023 | 10-Q Nov 9, 2023 | ||
What the company wroteOn August 24, 2023, Ms. Kira Wampler, a director of the Company, adopted a Rule 10b5-1 trading arrangement for the sale of securities of the Company’s common stock (a “Rule 10b5-1 Trading Plan”) that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Ms. Wampler’s Rule 10b5-1 Trading Plan, which has a term from August 24, 2023 to November 29, 2024, provides for the exercise and sale of 37,500 shares of common stock pursuant to a series of market orders. | |||||
| Mr. Craig Overpeck Senior Vice President of Commercial Operations |
Adopted 10b5-1 plan | May 26, 2023 | 10-Q Aug 8, 2023 | ||
What the company wroteOn May 26, 2023, Mr. Craig Overpeck, the Senior Vice President of Commercial Operations of the Company, adopted a Rule 10b5-1 trading arrangement for the sale of securities of the Company’s common stock (a “Rule 10b5-1 Trading Plan”) that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Mr. Overpeck’s Rule 10b5-1 Trading Plan, which has a term from May 26, 2023 to November 29, 2024, provides for the sale of 9,500 shares of common stock pursuant to a series of market orders. | |||||
Show the other 12 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 26, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Nov 5, 2026 | TIMOTHY STEPHEN CABRAL Director |
10,721 | $375K |
| Nov 2, 2026 | KIRA WAMPLER Director |
2,000 | $66K |
| Oct 14, 2026 | SIDDHARTH SITARAM Officer |
2,613 | $80K |
| Oct 1, 2026 | KIRA WAMPLER Director |
2,000 | $58K |
| Sep 30, 2026 | PHOEBE L YANG WATKIN Director |
1,290 | $34K |
| Sep 15, 2026 | SIDDHARTH SITARAM Officer |
2,077 | $54K |
| Sep 1, 2026 | KIRA WAMPLER Director |
2,000 | $53K |
| Aug 25, 2026 | KIRA WAMPLER Director |
2,000 | $50K |
| Aug 13, 2026 | SIDDHARTH SITARAM Officer |
1,770 | $44K |
| Aug 7, 2026 | TIMOTHY STEPHEN CABRAL Director |
7,500 | $293K |
| Jul 15, 2026 | SIDDHARTH SITARAM Officer |
1,732 | $38K |
| Jun 9, 2026 | ANNA COLLINS BRYSON Officer |
63,834 | $1.3M |
| Jun 8, 2026 | SIDDHARTH SITARAM Officer |
2,444 | $50K |
| May 11, 2026 | SIDDHARTH SITARAM Officer |
2,309 | $60K |
| May 7, 2026 | KIRA WAMPLER Director |
9,000 | $235K |
| Apr 10, 2026 | SIDDHARTH SITARAM Officer |
2,427 | $51K |
| Mar 10, 2026 | SIDDHARTH SITARAM Officer |
2,319 | $59K |
| Mar 3, 2026 | KIRA WAMPLER Director |
2,000 | $52K |
| Feb 2, 2026 | KIRA WAMPLER Director |
2,000 | $75K |
| Jan 2, 2026 | KIRA WAMPLER Director |
2,000 | $89K |
| Dec 1, 2025 | KIRA WAMPLER Director |
2,000 | $101K |
| Nov 21, 2025 | TIMOTHY CABRAL Director |
10,000 | $500K |
Show the other 14 notices
From the Form 144 XML filed with the SEC, since Nov 21, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/DOCS/export.csv") into a cell.